Background: Obesity and hypertriglyceridemia are complex metabolic conditions that arise from the expansion of white adipose tissue and dysfunction in lipid metabolism. Given the limitations of conventional therapies, plant-derived extracts have been investigated as promising alternative strategies. Objectives: The present study aimed to characterize the phytochemical profile of the hydroethanolic extract from Anemopaegma arvense leaves (HEAa), assess its toxicological safety, and investigate its effects on metabolic phenotype safety related to lipid accumulation using complementary biological models. Methods: HEAa was chemically characterized by LC-DAD-MS, and its toxicological profile was assessed using complementary in vitro, ex vivo, and in vivo models. Its effects on lipid-related metabolic phenotypes were assessed in adipocytes, Caenorhabditis elegans, and Wistar rats with high-fructose diet (HFrD)-induced body-weight gain and hyperlipidemia after 70 days of treatment. Results: HPLC-DAD-MS analysis revealed a chemically diverse profile composed mainly of flavonol glycosides, hydroxycinnamic acid derivatives, lipid-derived compounds, triterpenoids, megastigmane glycosides, and pheophorbide a; rutin was confirmed by comparison with an authentic standard. HEAa showed no hemolytic activity in human erythrocytes and did not reduce viability in C. elegans under the tested conditions. In 3T3-F442A adipocytes and C. elegans, HEAa produced modest reductions in neutral lipid accumulation. In high-fructose-fed Wistar rats, repeated HEAa administration reduced body-weight gain by approximately 53% and serum triglycerides by approximately 56% compared with untreated high-fructose-fed animals. Increases in ALT and AST levels were observed following prolonged exposure. Conclusions: HEAa modulated lipid accumulation and obesity-related metabolic phenotypes across complementary experimental models, with effects on body-weight gain and hypertriglyceridemia in rats fed a high-fructose diet. These findings support further investigation of A. arvense as a botanical candidate for metabolic disorders, nevertheless, the increases in hepatic enzymes highlight the need for additional studies to define its long-term safety.